LBF20207PG55: Difference between revisions
(New page: {{{Lipid/Header}} {{Hierarchy|{{PAGENAME}}}} {{Metabolite |LipidBank=XPR1745 |LipidMaps=LMFA03010063 |SysName=9-Oxo- (11alpha,15R) -dihydroxy-15-methyl-prosta- (5-cis,13-trans) -dien-1-...) |
No edit summary |
||
| Line 1: | Line 1: | ||
{{{Lipid/Header}} | {{{Lipid/Header}} | ||
| Line 7: | Line 6: | ||
|LipidBank=XPR1745 | |LipidBank=XPR1745 | ||
|LipidMaps=LMFA03010063 | |LipidMaps=LMFA03010063 | ||
|SysName=9-Oxo- (11alpha,15R) -dihydroxy-15-methyl-prosta- (5- | |SysName=9-Oxo- (11alpha,15R) -dihydroxy-15-methyl-prosta- (cis-5,trans-13) -dien-1-oic acid | ||
|Common Name=&&15R-15-methyl Prostaglandin E_2&&9-Oxo- (11alpha,15R) -dihydroxy-15-methyl-prosta- (5Z,13E) -dien-1-oic acid&& | |Common Name=&&15R-15-methyl Prostaglandin E_2&&9-Oxo- (11alpha,15R) -dihydroxy-15-methyl-prosta- (5Z,13E) -dien-1-oic acid&& | ||
|Source= | |Source= | ||
Latest revision as of 08:41, 21 October 2010
{
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1745 |
| LipidMaps | LMFA03010063 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20207PG55 |
| 15R-15-methyl Prostaglandin E2 | |
|---|---|
| |
| Structural Information | |
| 9-Oxo- (11α,15R) -dihydroxy-15-methyl-prosta- (cis-5,trans-13) -dien-1-oic acid | |
| |
| Formula | C21H34O5 |
| Exact Mass | 366.240624198 |
| Average Mass | 366.49166 |
| SMILES | C(=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](CC1=O)O)[C@@](C)(O)CCCCC |
| Physicochemical Information | |
| 15(R)-15-methyl Prostaglandin E2 shows increase of bicarbonate secretion in duodenum and inhibition of gastric acid secretion. Takanashi_H et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
